SCHEMBL12366256

SCHEMBL12366256

[C-]#[N+]c1c(C(F)(F)F)cc(-c2cccc(C)c2)n(Cc2cccc(C)c2)c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 6/20 0.37
TP53 P04637 5/20 0.37
LMNA P02545 3/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RGS4 P49798 1/20 0.36
RGS8 P57771 1/20 0.36
CLPP Q16740 1/20 0.36
MDM2 Q00987 1/20 0.36
CNR1 P21554 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366241 0.95 CNR1 (0.42) POLBMEN1KMT2AMAPTTP53
SCHEMBL12366233 0.95 CNR1 (0.42) MEN1KMT2AMAPTTP53ALDH1A1
SCHEMBL12366286 0.94 MAPT (0.45) POLBMAPTTP53LMNAALDH1A1
SCHEMBL12366418 0.94 MAPT (0.42) POLBMAPTTP53LMNAALDH1A1
SCHEMBL12366472 0.93 LMNA (0.45) POLBMEN1KMT2AMAPTTP53
SCHEMBL12366740 0.93 PTGS2 (0.35) POLBMEN1KMT2AMAPTTP53
SCHEMBL12366250 0.93 MAPT (0.40) MAPTTP53MDM2CNR1PTGS1
SCHEMBL12366465 0.92 MDM2 (0.36) POLBMAPTTP53CLPPMDM2
SCHEMBL12366743 0.91 MDM2 (0.34) MAPTTP53LMNAALDH1A1HTT
SCHEMBL12366450 0.91 MDM2 (0.40) POLBMAPTTP53LMNACLPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed